Evidence against a cytochrome P450-derived reactive oxygen species as the mediator of the nitric oxide-independent vasodilator effect of bradykinin in the perfused heart of the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 280, Issue 2, 1997, Pages 702-709

  Fulton, D ^a   Mcgiff, J C ^a   Wolin, M S ^a   Kaminski, P ^a   Quilley, J ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 6 BROMO 8 METHYLAMINOIMIDAZO[1,2 A]PYRAZINE 2 CARBONITRILE; ARACHIDONIC ACID; BRADYKININ; CATALASE; CLOTRIMAZOLE; CROMAKALIM; CYTOCHROME P450; HEPARIN; HYDROGEN PEROXIDE; ICOSATRIENOIC ACID; LUCIGENIN; N(G) NITROARGININE; NITRIC OXIDE; PENTOBARBITAL; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; TIRON; UNSPECIFIC MONOOXYGENASE; VASODILATOR AGENT; XANTHINE OXIDASE;

ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY; DRUG EFFECT; HEART PERFUSION; HYPERPOLARIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; ISOLATED HEART; KIDNEY MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; VASODILATATION;

ANIMALS; ARACHIDONIC ACID; BENZIMIDAZOLES; BENZOPYRANS; BRADYKININ; CHEMILUMINESCENT MEASUREMENTS; CROMAKALIM; CYCLIC N-OXIDES; CYTOCHROME P-450 ENZYME SYSTEM; FREE RADICAL SCAVENGERS; HEART; HYDROGEN PEROXIDE; IMIDAZOLES; INDOMETHACIN; KIDNEY CORTEX; MALE; MICROSOMES; NITRIC OXIDE; NITROARGININE; PARASYMPATHOLYTICS; PERFUSION; PYRAZINES; PYRROLES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VASODILATOR AGENTS;

EID: 0030933610     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. BAUERSACHS, J., HECKER, M. AND BUSSE, R.: Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br. J. Pharmacol. 113: 1548-1553, 1994.
2. BECKMAN, J. S., MINOR, R. L., WHITE, C. . W., REPINE, J. E., ROSEN, G. M. AND FREEMAN, B. A.: Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance. J. Biol. Chem. 263: 6884-6892, 1988.
3. BENY, J. L. AND VON DER WEID, P. Y.: Hydrogen peroxide: An endogenous smooth muscle cell hyperpolarizing factor. Biochem. Biophys. Res. Commun. 176: 378-384, 1991.
4. BONDY, S. C. AND NADERI, S.: Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem. Pharmacol. 48: 155-159, 1994.
5. BROADLEY, K. J.: The Langendorff heart preparation: Reappraisal of its role as a research and teaching model for coronary vasoactive drugs. J. Pharmacol. Methods 2: 143-156, 1979.
6. CAMPBELL, W. B., GEBREMEDHIN, D., PRATT, P. F. AND HARDER, D. R.: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res. 78: 415-423, 1996.
7. CHEN, G., SUZUKI, H. AND WESTON, A. H.: Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br. J. Pharmacol. 95: 1165-1174, 1988.
8. FULTON, D., BALAZY, M., MCGIFF, J. C. AND QUILLEY, J.: Possible contribution of platelet cyclooxygenase to the renal vascular action of 5,6-epoxyeicosatrienoic acid. J. Pharmacol. Exp. Ther. 277: 1195-1199, 1996.
9. FULTON, D., MAHBOUBI, K., MCGIFF, J. C. AND QUILLEY, J.: Cytochrome P450-dependent effects of bradykinin in the rat heart. Br. J. Pharmacol. 114: 99-102, 1995.
10. FULTON, D., MCGIFF, J. C. AND QUILLEY, J.: Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br. J. Pharmacol. 107:722-725, 1992.
11. FULTON, D., MCGIFF, J. C. AND QUILLEY, J.: Role of phospholipase C and phospholipase A2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart. J. Pharmacol. Exp. Ther. 278: 518-526, 1996.
12. + channels in the vasodilator response to bradykinin in the rat heart. Br. J. Pharmacol. 113: 954-958, 1994.
13. FURCHGOTT, R. F. AND ZAWADSKI, J. V.: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
14. HARDER, D. R., CAMPBELL, W. B. AND ROMAN, R. J.: Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32: 79-92, 1995.
15. HECKER, M., BARA, A. T., BAUERSACHS, J. AND BUSSE, R.: Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol. Lond. 481: 407-414, 1994.
16. HOLLAND, J. A., PRITCHARD, K. A., PAPPOLLA, M. A., WOLIN, M. S., ROGERS, N. J. AND STEMERMAN, M. B.: Bradykinin induces Superoxide anion release from human endothelial cells. J. Cell Physiol. 143: 21-25, 1990.
17. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur. J. Pharmacol. 230: 215-221, 1993.
18. IGNARRO, L. J., BUGA, G. M., WOOD, K. S., BYRNS, K. S. AND CHAUDHURI, G.: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Soc. Natl. Acad. Sci. USA 84: 9265-9269, 1987.
19. KOMORI, K., LORENZ, R. R. AND VANHOUTTE, P. M.: Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am. J. Physiol. 255: H207-H212, 1988.
20. KONTOS, H. A., WEI, E. P., KUKREJA, R. C., ELLIS, E. F. AND HESS, M. L.: Differences in endothelium-dependent cerebral dilation by bradykinin and acetylcholine. Am. J. Physiol. 258: H1261-H1266, 1990.
21. KUKREJA, R. C. AND HESS, M. L.: The oxygen free radical system: From equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc. Res. 26: 641-655, 1992.
22. LEDENEV, A. N., KONSTANTINOV, A. A., POPOVA, E. AND RUUGE, E. K.: A simple assay of the Superoxide anion generation rate with Tiron as an EPR-visible radical scavenger. Biochem. Internat. 13: 391-396, 1986.
23. + channels in bovine tracheal smooth muscle cells in culture. Br. J. Pharmacol. 116: 1656-1660, 1995.
24. 2 production via NADH-derived Superoxide. Am. J. Physiol. 270: H1044-H1053, 1996.
25. PACICCA, C., VON DER WEID, P. Y. AND BENY, J. L.: Effect of nitro-L-arginine on endothelium-dependent hyperpolarizations and relaxations of pig coronary arteries. J. Physiol. (Lond.) 457: 247-256, 1992.
26. PAKY, A., MICHAEL, J. R., BURKE-WOLIN, T. M., WOLIN, M. S., GURTNER, G. H.: Endogenous production of Superoxide by rabbit lungs: Effects of hypoxia or metabolic inhibitors. J. Appl. Physiol. 74: 2868-3874, 1993.
27. PALMER, R. M., ASHTON, D. S. AND MONCADA, S.: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
28. ROSENBLUM, W. I.: Hydroxyl radical mediates the endothelium-dependent relaxation produced by bradykinin in mouse cerebral arterioles. Circ. Res. 61: 601-603, 1987.
29. ROSOLOWSKY, M., FALCK, J. R. AND CAMPBELL, W. B.: Synthesis and biological activity of epoxyeicosatrienoic acids (E. E. T.s) by cultured bovine coronary artery endothelial cells. Adv. Prostaglandin Thromb. Leukot. Res. 21A: 213-216, 1991.
30. SHIMIZU, S., ISHII, M., YAMAMOTO, T., KAWANISHI, T., MOMOSE, K. AND KUROIWA, Y.: Bradykinin induces generation of reactive oxygen species in bovine aortic endothelial cells. Res. Commun. Chem. Pathol. Pharmacol. 84: 301-314, 1994.
31. WOLIN, M. S.: Reactive oxygen species and vascular signal transduction mechanisms. Microcirculation 3: 1-17, 1996.
32. + channel activity in renal arterioles. Hypertension 24: 382, 1994.